Pancreatic Cancer Research

ResearcherMayo Clinic in FloridaNo recent work listed

Jinping Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4891-922X; OpenAlex author ID A5100603466. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 3

  1. HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation. First author DOI 10.1186/s12935-020-01248-1↗
  2. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.cca.2018.11.023↗
  3. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma. Last author DOI 10.3390/ijms16022956↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shi‐Wen Jiang · 3 shared papers, 2015–2020 · strength 0.30
  2. Fengbiao Guo · 2 shared papers, 2019–2020 · strength 0.26
  3. Eseosaserea Igbinigie · 1 shared paper, 2019 · strength 0.12
  4. Christopher K. Senkowski · 1 shared paper, 2015 · strength 0.05
  5. Tianhe Huang · 1 shared paper, 2015 · strength 0.05
  6. Steven T. Brower · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.